Lei Fang
Corporate Officer/Principal bei LEPU BIOPHARMA CO., LTD.
Profil
Lei Fang is currently the Vice President at Lepu Biopharma Co., Ltd.
and also holds a current position at CtM Bio Co., Ltd.
Dr. Fang was previously the Director of Research & Development at I-MAB Biopharma Co., Ltd.
from 2016 to 2020.
Additionally, Dr. Fang was a Director at Third Venture Biopharma (Nanjing) Co., Ltd.
Dr. Fang received a doctorate degree from the Chinese Academy of Sciences and an undergraduate degree from Hebei University in 2004.
Aktive Positionen von Lei Fang
| Unternehmen | Position | Beginn |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Corporate Officer/Principal | 10.12.2020 |
| CtM Bio Co., Ltd. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Lei Fang
| Unternehmen | Position | Ende |
|---|---|---|
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 |
| Third Venture Biopharma (Nanjing) Co., Ltd. | Direktor/Vorstandsmitglied | - |
Ausbildung von Lei Fang
| Chinese Academy of Sciences | Doctorate Degree |
| Hebei University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
| CtM Bio Co., Ltd. | |
| Third Venture Biopharma (Nanjing) Co., Ltd. |
